title: Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age.
abstract: The diagnosis and follow-up process of adult patients with acute myeloid leukaemia (AML) is challenging to clinicians and laboratory staff alike. While several sets of recommendations have been published over the years, the development of high throughput screening and characterization for both genetic and epigenetic events have evolved with astonishing speed. Here we attempt to provide a practical guide to diagnose and follow adult AML patients with a focus on how to balance the wealth of information on the one hand, with the restriction put on these processes in terms of time, feasibility and economy when caring for these patients, on the other.
authors.affiliation: Department of Haematology, Aarhus University Hospital, Aarhus C, Denmark.
authors.forename: Anne S
authors.initials: AS
authors.lastname: Roug
authors.forename: Marcus C
authors.initials: MC
authors.lastname: Hansen
authors.forename: Line
authors.initials: L
authors.lastname: Nederby
authors.forename: Peter
authors.initials: P
authors.lastname: Hokland
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D001707:Biopsy, Needle; D001853:Bone Marrow / Q000473:pathology; D020732:Cytogenetic Analysis; D005434:Flow Cytometry / Q000379:methods; D023281:Genomics / Q000379:methods*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D008134:Long-Term Care / Q000379:methods; D018365:Neoplasm, Residual; D011379:Prognosis; D012074:Remission Induction; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor
keywords: acute myeloid leukaemia; diagnostic haematology; leukaemia markers; minimal residual disease; prognostic factors